nodes	percent_of_prediction	percent_of_DWPC	metapath
Pipotiazine—ALB—Acitretin—psoriasis	0.138	0.14	CbGbCtD
Pipotiazine—CYP1A2—Clobetasol propionate—psoriasis	0.128	0.13	CbGbCtD
Pipotiazine—CYP1A2—Methoxsalen—psoriasis	0.0672	0.0684	CbGbCtD
Pipotiazine—ALB—Mycophenolate mofetil—psoriasis	0.0645	0.0656	CbGbCtD
Pipotiazine—CYP2D6—Hydroxyurea—psoriasis	0.0605	0.0616	CbGbCtD
Pipotiazine—ALB—Prednisone—psoriasis	0.0516	0.0525	CbGbCtD
Pipotiazine—CYP2C19—Cholecalciferol—psoriasis	0.0482	0.0491	CbGbCtD
Pipotiazine—CYP3A4—Calcitriol—psoriasis	0.0453	0.0461	CbGbCtD
Pipotiazine—CYP2D6—Cholecalciferol—psoriasis	0.0367	0.0373	CbGbCtD
Pipotiazine—CYP3A4—Methoxsalen—psoriasis	0.0352	0.0358	CbGbCtD
Pipotiazine—CYP2C19—Prednisone—psoriasis	0.0334	0.034	CbGbCtD
Pipotiazine—CYP2C19—Cyclosporine—psoriasis	0.0317	0.0323	CbGbCtD
Pipotiazine—ALB—Methotrexate—psoriasis	0.0259	0.0263	CbGbCtD
Pipotiazine—CYP2D6—Cyclosporine—psoriasis	0.0241	0.0245	CbGbCtD
Pipotiazine—CYP3A4—Cholecalciferol—psoriasis	0.0233	0.0237	CbGbCtD
Pipotiazine—CYP2C19—Dexamethasone—psoriasis	0.0209	0.0212	CbGbCtD
Pipotiazine—CYP3A4—Mycophenolate mofetil—psoriasis	0.0202	0.0206	CbGbCtD
Pipotiazine—CYP3A4—Triamcinolone—psoriasis	0.0202	0.0206	CbGbCtD
Pipotiazine—CYP3A4—Betamethasone—psoriasis	0.0173	0.0177	CbGbCtD
Pipotiazine—CYP3A4—Prednisolone—psoriasis	0.0171	0.0174	CbGbCtD
Pipotiazine—CYP3A4—Hydrocortisone—psoriasis	0.0162	0.0165	CbGbCtD
Pipotiazine—CYP3A4—Prednisone—psoriasis	0.0162	0.0164	CbGbCtD
Pipotiazine—CYP2D6—Dexamethasone—psoriasis	0.0159	0.0161	CbGbCtD
Pipotiazine—CYP3A4—Cyclosporine—psoriasis	0.0153	0.0156	CbGbCtD
Pipotiazine—CYP3A4—Dexamethasone—psoriasis	0.0101	0.0103	CbGbCtD
Pipotiazine—HTR1A—SIDS Susceptibility Pathways—IL13—psoriasis	9.75e-05	0.0057	CbGpPWpGaD
Pipotiazine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	9.62e-05	0.00562	CbGpPWpGaD
Pipotiazine—ALB—Hemostasis—SERPINB8—psoriasis	9.5e-05	0.00556	CbGpPWpGaD
Pipotiazine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	9.21e-05	0.00538	CbGpPWpGaD
Pipotiazine—DRD2—GPCR ligand binding—HCAR2—psoriasis	9.11e-05	0.00533	CbGpPWpGaD
Pipotiazine—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—psoriasis	9.07e-05	0.0053	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR ligand binding—HCAR2—psoriasis	8.96e-05	0.00524	CbGpPWpGaD
Pipotiazine—HTR1A—G alpha (i) signalling events—CCL20—psoriasis	8.9e-05	0.00521	CbGpPWpGaD
Pipotiazine—CYP1A2—Biological oxidations—CYP2S1—psoriasis	8.63e-05	0.00505	CbGpPWpGaD
Pipotiazine—CYP1A2—Metapathway biotransformation—CYP2S1—psoriasis	8.51e-05	0.00498	CbGpPWpGaD
Pipotiazine—CYP1A2—Estrogen Receptor Pathway—STAT3—psoriasis	8.5e-05	0.00497	CbGpPWpGaD
Pipotiazine—HTR2A—SIDS Susceptibility Pathways—IL13—psoriasis	8.43e-05	0.00493	CbGpPWpGaD
Pipotiazine—CYP1A2—Melatonin metabolism and effects—APOE—psoriasis	8.37e-05	0.00489	CbGpPWpGaD
Pipotiazine—DRD1—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	8.23e-05	0.00481	CbGpPWpGaD
Pipotiazine—ALB—Folate Metabolism—CAT—psoriasis	7.97e-05	0.00466	CbGpPWpGaD
Pipotiazine—DRD2—G alpha (i) signalling events—CCL20—psoriasis	7.81e-05	0.00457	CbGpPWpGaD
Pipotiazine—ALB—Vitamin B12 Metabolism—CRP—psoriasis	7.78e-05	0.00455	CbGpPWpGaD
Pipotiazine—ALB—Lipid and lipoprotein metabolism—APOE—psoriasis	7.74e-05	0.00453	CbGpPWpGaD
Pipotiazine—ALB—Vitamin B12 Metabolism—APOE—psoriasis	7.62e-05	0.00445	CbGpPWpGaD
Pipotiazine—CYP1A2—Tryptophan metabolism—CAT—psoriasis	7.45e-05	0.00435	CbGpPWpGaD
Pipotiazine—ALB—Folate Metabolism—IL4—psoriasis	7.33e-05	0.00428	CbGpPWpGaD
Pipotiazine—ALB—Vitamin B12 Metabolism—ICAM1—psoriasis	7.15e-05	0.00418	CbGpPWpGaD
Pipotiazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	7.1e-05	0.00416	CbGpPWpGaD
Pipotiazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	7.08e-05	0.00414	CbGpPWpGaD
Pipotiazine—DRD1—GPCR downstream signaling—HCAR2—psoriasis	6.82e-05	0.00399	CbGpPWpGaD
Pipotiazine—SLC22A1—SLC-mediated transmembrane transport—CP—psoriasis	6.78e-05	0.00397	CbGpPWpGaD
Pipotiazine—CYP3A4—Biological oxidations—CYP2S1—psoriasis	6.66e-05	0.0039	CbGpPWpGaD
Pipotiazine—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	6.57e-05	0.00384	CbGpPWpGaD
Pipotiazine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	6.42e-05	0.00375	CbGpPWpGaD
Pipotiazine—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	6.39e-05	0.00374	CbGpPWpGaD
Pipotiazine—ALB—Selenium Micronutrient Network—CAT—psoriasis	6.34e-05	0.00371	CbGpPWpGaD
Pipotiazine—ALB—Folate Metabolism—CRP—psoriasis	6.33e-05	0.0037	CbGpPWpGaD
Pipotiazine—DRD1—GPCR ligand binding—CCL20—psoriasis	6.27e-05	0.00367	CbGpPWpGaD
Pipotiazine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	6.21e-05	0.00363	CbGpPWpGaD
Pipotiazine—DRD1—Signaling by GPCR—HCAR2—psoriasis	6.19e-05	0.00362	CbGpPWpGaD
Pipotiazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	6.11e-05	0.00358	CbGpPWpGaD
Pipotiazine—HTR1A—SIDS Susceptibility Pathways—IL10—psoriasis	6.1e-05	0.00357	CbGpPWpGaD
Pipotiazine—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	5.87e-05	0.00344	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR downstream signaling—HCAR2—psoriasis	5.86e-05	0.00343	CbGpPWpGaD
Pipotiazine—ALB—Folate Metabolism—ICAM1—psoriasis	5.82e-05	0.0034	CbGpPWpGaD
Pipotiazine—CYP3A4—Tryptophan metabolism—CAT—psoriasis	5.75e-05	0.00336	CbGpPWpGaD
Pipotiazine—ALB—Vitamin B12 Metabolism—IFNG—psoriasis	5.44e-05	0.00318	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR ligand binding—CCL20—psoriasis	5.39e-05	0.00315	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—HCAR2—psoriasis	5.32e-05	0.00311	CbGpPWpGaD
Pipotiazine—HTR2A—SIDS Susceptibility Pathways—IL10—psoriasis	5.27e-05	0.00308	CbGpPWpGaD
Pipotiazine—DRD2—GPCR downstream signaling—HCAR2—psoriasis	5.15e-05	0.00301	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR downstream signaling—HCAR2—psoriasis	5.07e-05	0.00296	CbGpPWpGaD
Pipotiazine—ALB—Selenium Micronutrient Network—CRP—psoriasis	5.03e-05	0.00294	CbGpPWpGaD
Pipotiazine—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	4.98e-05	0.00291	CbGpPWpGaD
Pipotiazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	4.95e-05	0.0029	CbGpPWpGaD
Pipotiazine—DRD1—Circadian rythm related genes—LEP—psoriasis	4.77e-05	0.00279	CbGpPWpGaD
Pipotiazine—DRD2—GPCR ligand binding—CCL20—psoriasis	4.73e-05	0.00277	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—HCAR2—psoriasis	4.67e-05	0.00273	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR ligand binding—CCL20—psoriasis	4.66e-05	0.00272	CbGpPWpGaD
Pipotiazine—ALB—Selenium Micronutrient Network—ICAM1—psoriasis	4.62e-05	0.0027	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—HCAR2—psoriasis	4.6e-05	0.00269	CbGpPWpGaD
Pipotiazine—ALB—SLC-mediated transmembrane transport—CP—psoriasis	4.54e-05	0.00265	CbGpPWpGaD
Pipotiazine—ALB—Vitamin B12 Metabolism—NFKB1—psoriasis	4.53e-05	0.00265	CbGpPWpGaD
Pipotiazine—DRD1—Circadian rythm related genes—NOS2—psoriasis	4.44e-05	0.0026	CbGpPWpGaD
Pipotiazine—ALB—Folate Metabolism—IFNG—psoriasis	4.43e-05	0.00259	CbGpPWpGaD
Pipotiazine—DRD1—Circadian rythm related genes—PPARG—psoriasis	4.15e-05	0.00243	CbGpPWpGaD
Pipotiazine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	4.13e-05	0.00242	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—NDUFA5—psoriasis	3.71e-05	0.00217	CbGpPWpGaD
Pipotiazine—ALB—Folate Metabolism—NFKB1—psoriasis	3.68e-05	0.00216	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—HCAR2—psoriasis	3.66e-05	0.00214	CbGpPWpGaD
Pipotiazine—DRD2—Circadian rythm related genes—LEP—psoriasis	3.6e-05	0.0021	CbGpPWpGaD
Pipotiazine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	3.57e-05	0.00209	CbGpPWpGaD
Pipotiazine—DRD1—GPCR downstream signaling—CCL20—psoriasis	3.54e-05	0.00207	CbGpPWpGaD
Pipotiazine—ALB—Vitamin B12 Metabolism—TNF—psoriasis	3.52e-05	0.00206	CbGpPWpGaD
Pipotiazine—ALB—Selenium Micronutrient Network—IFNG—psoriasis	3.52e-05	0.00206	CbGpPWpGaD
Pipotiazine—SLC22A1—Transmembrane transport of small molecules—CP—psoriasis	3.45e-05	0.00202	CbGpPWpGaD
Pipotiazine—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	3.44e-05	0.00201	CbGpPWpGaD
Pipotiazine—DRD2—Circadian rythm related genes—NOS2—psoriasis	3.35e-05	0.00196	CbGpPWpGaD
Pipotiazine—HTR1A—SIDS Susceptibility Pathways—CXCL8—psoriasis	3.34e-05	0.00195	CbGpPWpGaD
Pipotiazine—SLC22A1—Transmembrane transport of small molecules—CARM1—psoriasis	3.29e-05	0.00192	CbGpPWpGaD
Pipotiazine—DRD1—Signaling by GPCR—CCL20—psoriasis	3.22e-05	0.00188	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—TAGAP—psoriasis	3.17e-05	0.00185	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—CYP2S1—psoriasis	3.15e-05	0.00184	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—HCAR2—psoriasis	3.15e-05	0.00184	CbGpPWpGaD
Pipotiazine—DRD2—Circadian rythm related genes—PPARG—psoriasis	3.13e-05	0.00183	CbGpPWpGaD
Pipotiazine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	3.12e-05	0.00183	CbGpPWpGaD
Pipotiazine—HTR1A—SIDS Susceptibility Pathways—JUN—psoriasis	3.1e-05	0.00181	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR downstream signaling—CCL20—psoriasis	3.05e-05	0.00178	CbGpPWpGaD
Pipotiazine—HTR1A—SIDS Susceptibility Pathways—NFKB1—psoriasis	2.99e-05	0.00175	CbGpPWpGaD
Pipotiazine—DRD1—Circadian rythm related genes—JUN—psoriasis	2.94e-05	0.00172	CbGpPWpGaD
Pipotiazine—ALB—Selenium Micronutrient Network—NFKB1—psoriasis	2.93e-05	0.00171	CbGpPWpGaD
Pipotiazine—HTR2A—SIDS Susceptibility Pathways—CXCL8—psoriasis	2.88e-05	0.00169	CbGpPWpGaD
Pipotiazine—ALB—Platelet degranulation—VEGFA—psoriasis	2.87e-05	0.00168	CbGpPWpGaD
Pipotiazine—ALB—Folate Metabolism—TNF—psoriasis	2.87e-05	0.00168	CbGpPWpGaD
Pipotiazine—ALB—Vitamin B12 Metabolism—IL6—psoriasis	2.84e-05	0.00166	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—CCL20—psoriasis	2.77e-05	0.00162	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—HCAR2—psoriasis	2.76e-05	0.00162	CbGpPWpGaD
Pipotiazine—ALB—Hemostasis—ITGAL—psoriasis	2.76e-05	0.00161	CbGpPWpGaD
Pipotiazine—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—psoriasis	2.73e-05	0.0016	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—TAGAP—psoriasis	2.73e-05	0.00159	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—HCAR2—psoriasis	2.72e-05	0.00159	CbGpPWpGaD
Pipotiazine—HTR1A—SIDS Susceptibility Pathways—VEGFA—psoriasis	2.71e-05	0.00158	CbGpPWpGaD
Pipotiazine—HTR2A—SIDS Susceptibility Pathways—JUN—psoriasis	2.68e-05	0.00157	CbGpPWpGaD
Pipotiazine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	2.68e-05	0.00157	CbGpPWpGaD
Pipotiazine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	2.68e-05	0.00157	CbGpPWpGaD
Pipotiazine—DRD2—GPCR downstream signaling—CCL20—psoriasis	2.67e-05	0.00156	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR downstream signaling—CCL20—psoriasis	2.63e-05	0.00154	CbGpPWpGaD
Pipotiazine—HTR2A—SIDS Susceptibility Pathways—NFKB1—psoriasis	2.58e-05	0.00151	CbGpPWpGaD
Pipotiazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—psoriasis	2.56e-05	0.0015	CbGpPWpGaD
Pipotiazine—ALB—Folate Metabolism—TP53—psoriasis	2.53e-05	0.00148	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—NDUFA5—psoriasis	2.48e-05	0.00145	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—CCL20—psoriasis	2.43e-05	0.00142	CbGpPWpGaD
Pipotiazine—HTR1A—G alpha (i) signalling events—CXCL8—psoriasis	2.4e-05	0.00141	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—TAGAP—psoriasis	2.39e-05	0.0014	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—CCL20—psoriasis	2.39e-05	0.0014	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—TAGAP—psoriasis	2.36e-05	0.00138	CbGpPWpGaD
Pipotiazine—HTR2A—SIDS Susceptibility Pathways—VEGFA—psoriasis	2.34e-05	0.00137	CbGpPWpGaD
Pipotiazine—HTR1A—SIDS Susceptibility Pathways—TNF—psoriasis	2.32e-05	0.00136	CbGpPWpGaD
Pipotiazine—ALB—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.31e-05	0.00135	CbGpPWpGaD
Pipotiazine—ALB—Folate Metabolism—IL6—psoriasis	2.31e-05	0.00135	CbGpPWpGaD
Pipotiazine—ALB—Transmembrane transport of small molecules—CP—psoriasis	2.31e-05	0.00135	CbGpPWpGaD
Pipotiazine—ALB—Selenium Micronutrient Network—TNF—psoriasis	2.28e-05	0.00133	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—NDUFA5—psoriasis	2.23e-05	0.0013	CbGpPWpGaD
Pipotiazine—DRD2—Circadian rythm related genes—JUN—psoriasis	2.22e-05	0.0013	CbGpPWpGaD
Pipotiazine—DRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	2.22e-05	0.0013	CbGpPWpGaD
Pipotiazine—ALB—Transmembrane transport of small molecules—CARM1—psoriasis	2.2e-05	0.00129	CbGpPWpGaD
Pipotiazine—DRD2—G alpha (i) signalling events—CXCL8—psoriasis	2.11e-05	0.00123	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—CYP2S1—psoriasis	2.11e-05	0.00123	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.08e-05	0.00121	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—NDUFA5—psoriasis	2.05e-05	0.0012	CbGpPWpGaD
Pipotiazine—HTR2A—SIDS Susceptibility Pathways—TNF—psoriasis	2.01e-05	0.00117	CbGpPWpGaD
Pipotiazine—DRD1—Circadian rythm related genes—TP53—psoriasis	1.94e-05	0.00114	CbGpPWpGaD
Pipotiazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	1.91e-05	0.00112	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—CCL20—psoriasis	1.9e-05	0.00111	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—CYP2S1—psoriasis	1.89e-05	0.00111	CbGpPWpGaD
Pipotiazine—HTR1A—SIDS Susceptibility Pathways—IL6—psoriasis	1.87e-05	0.0011	CbGpPWpGaD
Pipotiazine—ALB—Selenium Micronutrient Network—IL6—psoriasis	1.84e-05	0.00107	CbGpPWpGaD
Pipotiazine—DRD1—Circadian rythm related genes—IL6—psoriasis	1.78e-05	0.00104	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—CYP2S1—psoriasis	1.74e-05	0.00102	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—NDUFA5—psoriasis	1.74e-05	0.00102	CbGpPWpGaD
Pipotiazine—DRD1—GPCR ligand binding—CXCL8—psoriasis	1.69e-05	0.00099	CbGpPWpGaD
Pipotiazine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	1.68e-05	0.000981	CbGpPWpGaD
Pipotiazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	1.65e-05	0.000966	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—CCL20—psoriasis	1.63e-05	0.000955	CbGpPWpGaD
Pipotiazine—HTR2A—SIDS Susceptibility Pathways—IL6—psoriasis	1.62e-05	0.000947	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.62e-05	0.000947	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—CARM1—psoriasis	1.54e-05	0.000901	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—CYP2S1—psoriasis	1.48e-05	0.000863	CbGpPWpGaD
Pipotiazine—DRD2—Circadian rythm related genes—TP53—psoriasis	1.47e-05	0.000858	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR ligand binding—CXCL8—psoriasis	1.46e-05	0.000851	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—CCL20—psoriasis	1.43e-05	0.000839	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—CCL20—psoriasis	1.41e-05	0.000825	CbGpPWpGaD
Pipotiazine—DRD2—Circadian rythm related genes—IL6—psoriasis	1.34e-05	0.000786	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—NDUFA5—psoriasis	1.34e-05	0.000783	CbGpPWpGaD
Pipotiazine—DRD2—GPCR ligand binding—CXCL8—psoriasis	1.28e-05	0.000747	CbGpPWpGaD
Pipotiazine—ALB—Platelet activation, signaling and aggregation—VEGFA—psoriasis	1.27e-05	0.000744	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR ligand binding—CXCL8—psoriasis	1.26e-05	0.000735	CbGpPWpGaD
Pipotiazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	1.25e-05	0.000732	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—CYP2S1—psoriasis	1.14e-05	0.000666	CbGpPWpGaD
Pipotiazine—ALB—Hemostasis—NOS2—psoriasis	1.13e-05	0.000662	CbGpPWpGaD
Pipotiazine—ALB—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.11e-05	0.000647	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—SOCS1—psoriasis	1.05e-05	0.000612	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—CARM1—psoriasis	1.03e-05	0.000603	CbGpPWpGaD
Pipotiazine—DRD1—Signaling by GPCR—TYK2—psoriasis	9.97e-06	0.000583	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.93e-06	0.000581	CbGpPWpGaD
Pipotiazine—ALB—Metabolism of lipids and lipoproteins—PPARG—psoriasis	9.63e-06	0.000563	CbGpPWpGaD
Pipotiazine—DRD1—GPCR downstream signaling—CXCL8—psoriasis	9.56e-06	0.000559	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—CAT—psoriasis	9.47e-06	0.000554	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—CARM1—psoriasis	9.25e-06	0.000541	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—SOCS1—psoriasis	9e-06	0.000526	CbGpPWpGaD
Pipotiazine—DRD1—Signaling by GPCR—CXCL8—psoriasis	8.68e-06	0.000508	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	8.65e-06	0.000506	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—TYK2—psoriasis	8.58e-06	0.000502	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—CARM1—psoriasis	8.51e-06	0.000498	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR downstream signaling—CXCL8—psoriasis	8.22e-06	0.000481	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—SOCS1—psoriasis	7.9e-06	0.000462	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—SOCS1—psoriasis	7.77e-06	0.000455	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	7.73e-06	0.000452	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—LEP—psoriasis	7.72e-06	0.000452	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—APOE—psoriasis	7.72e-06	0.000452	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—TYK2—psoriasis	7.53e-06	0.00044	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—CXCL8—psoriasis	7.47e-06	0.000437	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—TYK2—psoriasis	7.41e-06	0.000433	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—APOE—psoriasis	7.36e-06	0.000431	CbGpPWpGaD
Pipotiazine—DRD2—GPCR downstream signaling—CXCL8—psoriasis	7.22e-06	0.000422	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—CARM1—psoriasis	7.21e-06	0.000422	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—NFKBIA—psoriasis	7.19e-06	0.000421	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR downstream signaling—CXCL8—psoriasis	7.1e-06	0.000416	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	6.74e-06	0.000394	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—APOE—psoriasis	6.64e-06	0.000388	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—LEP—psoriasis	6.64e-06	0.000388	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—CXCL8—psoriasis	6.56e-06	0.000383	CbGpPWpGaD
Pipotiazine—ALB—Hemostasis—VEGFA—psoriasis	6.56e-06	0.000383	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—CXCL8—psoriasis	6.45e-06	0.000377	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—PPARG—psoriasis	6.41e-06	0.000375	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—CAT—psoriasis	6.34e-06	0.000371	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—NFKBIA—psoriasis	6.19e-06	0.000362	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—TYK2—psoriasis	5.89e-06	0.000345	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—LEP—psoriasis	5.83e-06	0.000341	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—APOE—psoriasis	5.83e-06	0.000341	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—APOE—psoriasis	5.74e-06	0.000335	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—LEP—psoriasis	5.74e-06	0.000335	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—CAT—psoriasis	5.69e-06	0.000333	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—CARM1—psoriasis	5.56e-06	0.000325	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—NFKBIA—psoriasis	5.43e-06	0.000318	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—NFKBIA—psoriasis	5.34e-06	0.000313	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—CAT—psoriasis	5.23e-06	0.000306	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—CXCL8—psoriasis	5.13e-06	0.0003	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—TYK2—psoriasis	5.07e-06	0.000296	CbGpPWpGaD
Pipotiazine—ALB—Hemostasis—TP53—psoriasis	4.95e-06	0.00029	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—APOE—psoriasis	4.92e-06	0.000288	CbGpPWpGaD
Pipotiazine—DRD1—Signaling by GPCR—IL6—psoriasis	4.88e-06	0.000285	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—JUN—psoriasis	4.77e-06	0.000279	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—NFKB1—psoriasis	4.59e-06	0.000269	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—TYK2—psoriasis	4.45e-06	0.00026	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—CAT—psoriasis	4.43e-06	0.000259	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—APOE—psoriasis	4.42e-06	0.000259	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—CXCL8—psoriasis	4.41e-06	0.000258	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—TYK2—psoriasis	4.38e-06	0.000256	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—PPARG—psoriasis	4.29e-06	0.000251	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—IL6—psoriasis	4.2e-06	0.000245	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—VEGFA—psoriasis	4.17e-06	0.000244	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—STAT3—psoriasis	4.13e-06	0.000241	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—JUN—psoriasis	4.1e-06	0.00024	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—APOE—psoriasis	4.07e-06	0.000238	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—NFKB1—psoriasis	3.95e-06	0.000231	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—CXCL8—psoriasis	3.87e-06	0.000227	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—PPARG—psoriasis	3.85e-06	0.000225	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—CXCL8—psoriasis	3.81e-06	0.000223	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—IL6—psoriasis	3.68e-06	0.000215	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—IL6—psoriasis	3.62e-06	0.000212	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—JUN—psoriasis	3.6e-06	0.000211	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—VEGFA—psoriasis	3.58e-06	0.00021	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—STAT3—psoriasis	3.55e-06	0.000207	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—JUN—psoriasis	3.54e-06	0.000207	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—PPARG—psoriasis	3.54e-06	0.000207	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—NFKB1—psoriasis	3.47e-06	0.000203	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—APOE—psoriasis	3.44e-06	0.000201	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—CAT—psoriasis	3.42e-06	0.0002	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—NFKB1—psoriasis	3.41e-06	0.000199	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—TP53—psoriasis	3.15e-06	0.000184	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—VEGFA—psoriasis	3.15e-06	0.000184	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—STAT3—psoriasis	3.12e-06	0.000182	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—VEGFA—psoriasis	3.1e-06	0.000181	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—STAT3—psoriasis	3.07e-06	0.000179	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—PPARG—psoriasis	3e-06	0.000175	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—IL6—psoriasis	2.88e-06	0.000169	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—TP53—psoriasis	2.71e-06	0.000158	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—APOE—psoriasis	2.66e-06	0.000155	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—IL6—psoriasis	2.48e-06	0.000145	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—TP53—psoriasis	2.38e-06	0.000139	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—TP53—psoriasis	2.34e-06	0.000137	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—PPARG—psoriasis	2.32e-06	0.000135	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—IL6—psoriasis	2.18e-06	0.000127	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—IL6—psoriasis	2.14e-06	0.000125	CbGpPWpGaD
